US FDA puts clinical hold on Atara's trials for cancer cell therapies

Atara Biotherapeutics

21/01/2025 12:40

Jan 21 (Reuters) - Atara Biotherapeutics  ATRA.O  said
on Tuesday the U.S. Food and Drug Administration has placed a
clinical hold on the drug developer's trials for its cancer cell
therapies.

 (Reporting by Kamal Choudhury in Bengaluru; Editing by Shilpi
Majumdar)
 ((Kamal.Choudhury@thomsonreuters.com))